SZSE Ticker: 300406

Beijing Strong Biotechnologies, Inc

北京九强生物技术股份有限公司

九强生物

BSBE

Listing Date: 2014-10-30

Board: GEM

Industry Classification: Manufacturing

Jiuqiang Bio: The fully automatic immunohistochemical analyzer and supporting antibody reagents produced by our company have strong international competitiveness and high technical threshold

Post date May 17, 2022 — 07:07 Post Lock

Jiuqiang Bio: The immune reagents produced by our company are only suitable for clinical diagnosis

Post date May 17, 2022 — 07:07 Post Lock

Jiuqiang Bio: The company's novel coronavirus (2019-nCOV) antigen detection kit (latex method) product has obtained EU CE access qualification

Post date May 17, 2022 — 07:06 Post Lock

Central Bureau Observation of Nucleic Acid Testing①｜The demand for new crown testing has changed from strong to weak, and the changes in the IVD industry and the new situation 21 Economic Net

Post date May 12, 2022 — 13:32 Post Lock

The first five-year plan for bio-economy was issued, and concept stocks pulled up the daily limit at the end of the session. Please collect the list of the latest performance growth! Multiple consecutive daily limit, this sector started a rebound mode

Post date May 11, 2022 — 09:48 Post Lock

2.389 billion yuan of main funds withdraw from the pharmaceutical and biological sector today_ Oriental Fortune Net

Post date May 10, 2022 — 18:18 Post Lock

Jiuqiang Bio: As of April 30, 2022, the cumulative repurchase of about 850,000 shares accounted for 0.1436% _ Oriental Fortune Net

Post date May 5, 2022 — 18:41 Post Lock

On April 29, the top nine biotech rose 5.58%, and the Rongtong health industry flexibly allocated a mixed A/B fund to hold a heavy position in the stock_Stock News_Market Gold Online

Post date April 29, 2022 — 17:20 Post Lock

Jiuqiang Bio (300406): Verification Opinion of Huachuang Securities Co., Ltd. on the realization of the 2021 annual performance commitment of Beijing Jiuqiang Biotechnology Co., Ltd.'s major asset purchase and related-party transactions- CFi.CN Zhongcai.com

Post date April 28, 2022 — 23:01 Post Lock

There have been changes in the executives of many pharmaceutical companies such as Asia Pacific Pharmaceuticals and Jiuqiang Bio

Post date April 20, 2022 — 11:41 Post Lock

New coronavirus antigen testing company has outstanding performance

Post date April 20, 2022 — 05:39 Post Lock

What are the well-known medical device listed companies? Ranking of leading stocks of listed companies producing medical devices

Post date April 17, 2022 — 20:17 Post Lock

Jiuqiang Bio: In the first half of 2021, the company achieved a year-on-year increase of 215.81% in sales revenue of traditional biochemical, hemagglutination reagents and immunohistochemical antibodies

Post date April 13, 2022 — 17:31 Post Lock

Jiuqiang Bio: In the first half of 2021, the company achieved a year-on-year increase of 215.81% in sales revenue of traditional biochemical, hemagglutination reagents and immunohistochemical antibodies.

Post date April 13, 2022 — 17:28 Post Lock

[Equity Transfer] Jiuqiang Bio (300406): Holding Subsidiary Completes Industrial and Commercial Change Registration of Equity Transfer CFi.CN Zhongcai Network

Post date April 13, 2022 — 17:22 Post Lock

The speed of "printing money" is comparable to that of Maotai! Jiu'an Medical once again hit the daily limit, earning 15 times the sum of the past ten years in one quarter

Post date April 12, 2022 — 16:11 Post Lock

7.4 billion funds rush to raise, 11 times the big bull stock and then the daily limit! The demand for new crown antigen testing has greatly increased, and the company's net profit in the first quarter has soared by more than 367 times

Post date April 12, 2022 — 15:02 Post Lock

The speed of "printing money" is comparable to that of Maotai! Jiu'an Medical once again hit the daily limit, earning 15 times the sum of the past ten years in one quarter! Stocks Financial World

Post date April 12, 2022 — 15:00 Post Lock

The pharmaceutical and biological industry fell 2.10% today, and the main capital net outflow was 8.075 billion yuan.

Post date April 7, 2022 — 17:54 Post Lock

Financial Associated Press April 7 Morning Post (Thursday) _ Oriental Fortune Net

Post date April 7, 2022 — 11:06 Post Lock

Want to see more data? Registered subscribers can see all the data.